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Objectives: the aim of the study was to determine the effects of infrarenal asymptomatic abdominal aortic aneurysm
(AAA) on platelet count and activation.
Design: prospective clinical study in a University Department of Vascular Surgery.
Patients: one hundred and five patients with AAA. Thirty-two control patients with symptomatic carotid artery stenoses.
Methods: platelet count (PC), plasma glycocalicin levels, prothrombin ratio (PTR), activated partial thromboplastin time
(APPT), fibrinogen and D-dimer were measured in 23 patients with AAA and 16 control patients with symptomatic
carotid artery stenoses. PC alone was measured in a further 84 patients with AAA and 16 with carotid artery stenoses.
Results: PC was below the normal range in 8/105 patients and mean PC (215·109/l, s.d. 47.5) was significantly lower
than that of a control population (242·109/l, s.d. 16.8) and patients with carotid disease (269·109/l, s.d. 57). Glycocalicin
level was above the normal range in 7/23 patients and the median level (28 fg/plt) was significantly higher than that of
a normal population (21.6 fg/plt) and patients with carotid disease (12.3 fg/plt). Fibrinogen levels, PTR and APPT were
all within the normal range. One patient had a minimally elevated level of D-dimer.
Conclusions: the combination of low PC and high glycocalicin levels suggests that there is increased platelet destruction,
most likely due to activation within the aneurysm sac.
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Introduction Patients and Methods
It is well recognised that patients with ruptured ab- Twenty-three patients with a diagnosis of AAA were
dominal aortic aneurysm (AAA) may develop a co- identified in the out-patient department. The diagnosis
agulopathy and that this is associated with a very was confirmed by ultrasonography. The antero-
poor prognosis.1 Subclinical abnormalities of the co- posterior diameter was recorded, as were clinical de-
agulation system have been reported in patients with tails such as age, past medical history and drug history.
non-ruptured aneurysms and there have been case The median age of patients was 69 years. The male:
reports of disseminated intravascular coagulation female ratio was 4.5:1. The mean aneurysm diameter
(DIC), attributed to the presence of an intact aortic was 48 mm (range 32–65 mm). Six patients were taking
aneurysm.2–5 It has been postulated that the co- regular aspirin.
agulation system may be “primed” in patients with Blood samples were taken from an antecubital vein
asymptomatic AAA and this may contribute to the without tourniquet occlusion. A 5 ml sample was taken
development of a coagulopathy should rupture occur.6 into EDTA for platelet count and a 5 ml sample was
The aims of this study were to determine, for the taken into citrate for glycocalicin, prothrombin ratio
first time, the presence and degree of activation of (PTR), activated partial thromboplastin time (APPT),
platelets in a population of patients with asymptomatic fibrinogen and D-dimer. Glycocalicin assay was per-
AAA. formed using an ELISA technique as previously de-
scribed and levels were corrected for platelet count,
as it has previously been shown that glycocalicin
level is proportional to platelet count in a normal
* Please address all correspondence to: A. A. Milne, Department of population.7Surgery, Queen Margaret Hospital, Whitefield Road, Dunfermline,
KY12 0SU, U.K. In addition to the above patients on whom complete
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Fig. 2. Glycocalicin levels in 23 patients with asymptomatic ab-
dominal aortic aneurysm and 16 patients with symptomatic carotid
artery stenosis. p=0.0001 by Mann–Whitney U-test.
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the normal range. The median plasma level of glyco-
Fig. 1. Platelet counts in 105 patients with asymptomatic abdominal calicin per platelet (28 fg/plt·108) was higher than
aortic aneurysm. Normal range 150–450·109/l. that of a normal population (21.6 fg/plt·108) p=0.001
and higher than that of patients with carotid disease
(12.3 fg/plt·108, s.d. 5.4) p=0.0001 by Mann–Whitneycoagulation studies were performed, platelet counts
(Fig. 2). All patients had plasma fibrinogen levelswere obtained from hospital records in a further 82
within the normal range, although these tended to bepatients admitted for elective AAA repair.
at the upper end of the range. One patient had aThe study group platelet counts were compared
minimally elevated level of D-dimer and this was notwith mean values for a hospital population of 2000
associated with any other abnormality on coagulationconsecutive samples and also with a group of 32
screen. All patients had a PTR and APPT within thepatients undergoing carotid endarterectomy for symp-
normal range. The platelet count, glycocalicin leveltomatic carotid stenoses who were recruited as part
and fibrinogen level did not correlate with size ofof other studies.8 The median age of these patients
aneurysm, age of patient or aspirin usage.was 67 years and the male to female ratio was 1.3:1.
Twenty-nine of these patients were taking regular
aspirin. Glycocalicin levels in 23 patients with AAA
were compared with values for a normal population
Discussionpreviously determined in this laboratory (mean
21.6 fg/plt, s.d. 8) and with 16 of the group of patients The present study has shown that in patients withwith symptomatic carotid stenoses. asymptomatic AAA the mean platelet count is about
10% lower than the control population and about 10%
of patients have platelet counts below the normal
range. These abnormalities cannot be attributed to theResults
presence of generalised vascular disease; in fact, such
patients would be expected to have higher than normalPlatelet counts were in the lower part of the normal
range and were below the normal range in 8/105 platelet counts, as found in the patients with carotid
disease.9patients (Fig. 1). The mean platelet count was
215·109/l (s.d. 47.5). This was significantly lower These low platelet counts are associated with high
levels of glycocalicin. This is not simply a statisticalthan that of a control population of 2000 consecutive
samples (mean platelet count 242·109/l, s.d. 16.8) – phenomenon due to the lower platelet counts in the
aneurysm group, as the absolute levels of glycocalicinp<0.0001 by T-test and significantly lower than the
patients with carotid disease (mean platelet count are also higher. Glycocalicin is the extra-membranous
portion of glycoprotein 1 (GP1b) produced when GP1b269·109/l, s.d. 57) – p<0.001 by T-test.
In 7/23 patients levels of glycocalicin were above is cleaved from the platelet membrane.10 It is a marker
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of platelet activation and turnover. The elevated glyco- ageing process which marks them for destruction is
poorly understood. It is known that coming into con-calicin levels found in patients with AAA cannot be
ascribed to generalised vascular disease; low levels tact with a foreign surface, such as subendothelium,
can activate platelets and such platelets are clearedof glycocalicin have been reported in patients with
from the circulation regardless of their age.18 Suchperipheral vascular disease and ischaemic heart dis-
activation of the platelet without adhesion may occurease and, in the present study, patients with symp-
within the aneurysm sac, producing changes to thetomatic carotid artery disease had lower levels of
circulating platelet which mark it for early destruction.glycocalicin than AAA patients.10 Although aspirin
The elevated glycocalicin levels may then be accountedusage was more common in the patients with carotid
for by one of two mechanisms. It may simply be thatdisease, this is unlikely to be the cause of this dif-
GP1b is released at the time of platelet destruction inference, as we have previously shown that glycocalicin
the reticuloendothelial system. The other explanationlevels are not affected by aspirin usage in normal
concerns the mechanism by which platelets are markedsubjects.8 It would therefore appear that the presence
for early clearance from the circulation. It has beenof AAA has a significant effect on platelets.
proposed that platelets undergo gradual loss of GP1bThe present study did not reveal any significant
throughout their life span and that this is the meansderangement of the soluble coagulation system, con-
by which senescent platelets are identified by thetrary to previous reports.3 There was no evidence of
reticuloendothelial system. It has been demonstratedexcessive fibrinolysis or consumption of clotting fac-
in vitro that activation of platelets can lead to thetors as shown by the normal PTR, APPT and D-dimer
generation of a protease which cleaves GP1b close tolevels. Fibrinogen levels in all patients were within
the site of its insertion onto the platelet membrane.normal limits but at the upper end of the normal
Thus it may be that activation within the sac causesrange, as would be expected in patients with vascular
release of GP1b, marking the platelet for early clear-disease.11 This negative finding may be due to the
ance. If this is the case, there may be circulatingrelatively small size of aneurysms in the study group,
platelets which are deficient in GP1b receptors.as the case reports of DIC have involved patients with
GP1b is central to the process of platelet adhesionlarge aneurysms.
at the site of vessel wall injury and thus vital for clotThere are four possible mechanisms for the low
formation and haemostasis. It is therefore easy toplatelet counts in patients with AAA: decreased rate
envisage that platelets deficient in GP1b would beof production, increased rate of destruction, platelet
dysfunctional. Such loss of GP1b occurs during plateletsequestration, e.g. in the spleen, and dilution. Dilution
storage in blood banks and has been proposed as theis unlikely, as this occurs when there is rapid expansion
reason for the decreased functional ability of storedof plasma volume. Likewise, there is no evidence for
platelets.19 Thus, in these patients there may be asequestration, such as splenomegaly. Decreased rate
combination of dysfunctional platelets and a mildof platelet production seems unlikely, as these patients
degree of thrombocytopenia which could significantlyare capable of producing a thrombocytosis following
compromise the coagulation system. Haemostaticsurgery.12,13 Thus, an increased rate of destruction
function in the resting state might be near normal, butseems the most likely cause of thrombocytopenia.
the threshold at which clinical bleeding problems occurThe simplest explanation is that platelets are ac-
would be much lower, and there would be little reservetivated by the clot in the aneurysm sac, adhere and
in the face of a major challenge to the haemostaticbecome incorporated into the clot. GP1b is released at
system such as aneurysm rupture or aortic operation.the time of activation, accounting for the elevated
In order to resolve these questions, more detailedglycocalicin. This process might be termed “con-
studies of expression of cell surface receptors aresumption within the sac”. If this is the case, then the
required, using techniques such as flow cytometry.remaining circulating platelets would have normal
Such studies would not only provide informationsurface expression of GP1b and function normally.
about platelet function in these patients but may alsoThis hypothesis is supported by studies using radio-
help to explain the mechanism by which senescentlabelling which have demonstrated that platelets and
platelets are identified and destroyed by the reticulo-fibrinogen are deposited in the clot within the an-
endothelial system.eurysm sac.14–16 A similar pattern of low platelet counts
and high glycocalicin levels has been described in
Acknowledgementspatients with rheumatic valve disease and was at-
tributed to platelet activation on the damaged valves.17
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